| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.83 | 0.0009 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.53 | 0.06 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.41 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.31 | 0.09 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.3 | 0.05 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.26 | 0.09 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.19 | 0.2 |